Evidence map›Paper›PMID 36729454›Full record

ArticleJAMA network open2023

Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022.

Kristina L Bajema, Mazhgan Rowneki, Kristin Berry, Amy Bohnert, C Barrett Bowling, Edward J Boyko, Theodore J Iwashyna, Matthew L Maciejewski, Ann M O'Hare, Thomas F Osborne and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05394025 (COVID-19 Observational Research Collaboratory - Long-Term Outcomes), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05394025 completednot on this map

COVID-19 Observational Research Collaboratory - Long-Term Outcomes (LTO) Study

TypeobservationalSponsorVA Office of Research and DevelopmentRan2022 to 2024Enrolled479ConditionsCOVID-19, SARS-CoV-2 Infection
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

Kristina L BajemaVeterans Affairs Portland Health Care System, Portland, Oregon.
Mazhgan RownekiCenter of Innovation to Improve Veteran Involvement in Care, Veterans Affairs Portland Health Care System, Portland, Oregon.
Kristin BerryCenter of Innovation for Veteran Centered Value Driven Care, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington.
Amy BohnertCenter for Clinical Management Research, Veterans Affairs Ann Arbor Health Care System, Ann Arbor, Michigan.
C Barrett BowlingDurham Veterans Affairs Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center, Durham, North Carolina.
Edward J BoykoSeattle Epidemiologic Research and Information Center, Veterans Affairs Puget Sound Healthcare Seattle, Washington.
Theodore J IwashynaCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Matthew L MaciejewskiDepartment of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
Ann M O'HareVeterans Affairs Puget Sound Healthcare Seattle, Washington.
Thomas F OsborneVeterans Affairs Palo Alto Healthcare System, Palo Alto, California.
Elizabeth M VigliantiCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Denise M HynesCenter of Innovation to Improve Veteran Involvement in Care, Veterans Affairs Portland Health Care System, Portland, Oregon.
George N IoannouDivision of Gastroenterology, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle.
VA Portland Health Care System · USVA Puget Sound Health Care System · USDuke University · USDurham VA Medical Center · USJohns Hopkins University · USOregon State University · USStanford University · USUniversity of Michigan–Ann Arbor · USUniversity of Puget Sound · USUniversity of Washington · USVA Center for Clinical Management Research · US

Funding

HSRD VA IK6 HX003395
6 · The paper itself

Abstract

Importance: COVID-19 vaccination rates remain suboptimal in the US. Identifying factors associated with vaccination can highlight existing gaps and guide targeted interventions to improve vaccination access and uptake. Objective: To describe incidence and patient characteristics associated with primary, first booster, and second booster COVID-19 vaccination in the Veterans Health Administration (VHA). Design, Setting, and Participants: This retrospective cohort study assessed US veterans receiving care in VHA medical centers and outpatient clinics as of December 1, 2020. All VHA enrollees with an inpatient, outpatient, or telehealth encounter in VHA as well as a primary care physician appointment in the preceding 24 months were included. Exposures: Demographic characteristics, place of residence, prior SARS-CoV-2 infection, and underlying medical conditions. Main Outcomes and Measures: Cumulative incidence of primary, first booster, and second booster COVID-19 vaccination through June 2022. Cox proportional hazards regression was used to identify factors independently associated with COVID-19 vaccination. Results: Among 5 632 413 veterans included in the study, 5 094 392 (90.4%) were male, the median (IQR) age was 66 (51-74) years, 1 032 334 (18.3%) were Black, 448 714 (8.0%) were Hispanic, and 4 202 173 (74.6%) were White. Through June 2022, cumulative incidences were 69.0% for primary vaccination, 42.9% for first booster, and 9.3% for second booster. Cumulative incidence for primary vaccination increased with increasing age, from 46.9% (95% CI, 46.8%-47.0%) among veterans aged 18 to 49 years to 82.9% (95% CI, 82.8%-83.0%) among veterans aged 80 to 84 years. More Black veterans completed primary vaccination (71.7%; 95% CI, 71.6%-71.8%) compared with White veterans (68.9%; 95% CI, 68.9%-69.0%), and more urban-dwelling veterans completed primary vaccination (70.9%; 95% CI, 70.9%-71.0%) compared with highly rural-dwelling veterans (63.8%; 95% CI, 63.4%-64.1%). Factors independently associated with higher likelihood of both primary and booster vaccination included older age, female sex, Asian or Black race, Hispanic ethnicity, urban residence, and lack of prior SARS-CoV-2 infection. Conclusions and Relevance: In this cohort study of US veterans, COVID-19 vaccination coverage through June 2022 was suboptimal. Primary vaccination can be improved among younger, rural-dwelling veterans. Greater uptake of booster vaccination among all veterans is needed.

Indexed as

COVID-19VeteransAdolescentAdultAmbulatory Care FacilitiesCohort StudiesCOVID-19 VaccinesFemaleHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2Young AdultCOVID-19 Vaccines

Identifiers

PMID36729454
PMCPMC9896301
OpenAlexW4318913280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.